Persistent viral infections in human carcinogenesis
- PMID: 8130717
- DOI: 10.1097/00008469-199401000-00002
Persistent viral infections in human carcinogenesis
Abstract
Several taxonomically distinct human pathogenic viruses capable of upholding persistent infections have been recognized as important carcinogens. Jointly they are characterized by going into decade-long interactions with host cells and/or tissues. Tumours arise after a long latent period in a few infected individuals. The cellular changes necessary for malignancy are only in part directly or indirectly caused by virus-cell interactions. Cofactors are assumed to be involved. The different routes to malignancy reflect the distinct strategies of each virus in its interaction with the host, which for the upkeep of chronic infections requires a tight control of both virus and cell multiplication and the extent to which an immune response is provoked. The size of the virus-cancer problem and the possibility of prevention makes virology one of the most promising areas of cancer prevention on a global scale. A much wider use of the vaccination against hepatitis B, especially in children, is warranted in developed countries.
Similar articles
-
[Epstein-Barr, hepatitis B and hepatitis C virus infections and their oncogenic potentials].Med Pregl. 1997 Nov-Dec;50(11-12):499-504. Med Pregl. 1997. PMID: 9471511 Croatian.
-
[Papillomaviruses pathogenic to human and their relationship to oncogenesis].Hautarzt. 1990 Dec;41(12):658-61. Hautarzt. 1990. PMID: 1965184 German.
-
Regulation of telomerase and telomeres: human tumor viruses take control.J Natl Cancer Inst. 2008 Jan 16;100(2):98-108. doi: 10.1093/jnci/djm269. Epub 2008 Jan 8. J Natl Cancer Inst. 2008. PMID: 18182620 Review.
-
Viral carcinogenesis: revelation of molecular mechanisms and etiology of human disease.Carcinogenesis. 2000 Mar;21(3):405-26. doi: 10.1093/carcin/21.3.405. Carcinogenesis. 2000. PMID: 10688861 Review.
-
Epstein-Barr virus infection and the pathogenesis of malignant lymphomas.Cancer Surv. 1997;30:143-62. Cancer Surv. 1997. PMID: 9547991 Review.
Cited by
-
Cancer risk in heart or lung transplant recipients: A comprehensive analysis of 21 prospective cohorts.Cancer Med. 2020 Dec;9(24):9595-9610. doi: 10.1002/cam4.3525. Epub 2020 Oct 13. Cancer Med. 2020. PMID: 33047902 Free PMC article.
-
Cancer Risks in Solid Organ Transplant Recipients: Results from a Comprehensive Analysis of 72 Cohort Studies.Oncoimmunology. 2020 Nov 29;9(1):1848068. doi: 10.1080/2162402X.2020.1848068. Oncoimmunology. 2020. PMID: 33299661 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources